Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitul Shah

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
Carcinogenesis|October 4, 2011
Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer StudyCatherine S Healey, Shahana Ahmed, , et al.
Human Molecular Genetics|August 1, 2013
A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer riskKaren A Pooley, Stig E Bojesen, Maren Weischer, et al.
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
Breast Cancer Research : BCR|October 8, 2016
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumTaru A Muranen, Carl Blomqvist, Thilo Dörk, et al.
Oncotarget|April 1, 2015
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patientsRainer Fagerholm, Marjanka K Schmidt, Sofia Khan, et al.
European Journal of Epidemiology|October 3, 2023
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancerKatharina Wichert, Reiner Hoppe, Katja Ickstadt, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Gynecologic Oncology|November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinomaNicola S Meagher, Phineas Hamilton, Katy Milne, et al.
Nature Genetics|April 19, 2011
Genome-wide association study identifies a common variant associated with risk of endometrial cancerAmanda B Spurdle, Deborah J Thompson, Shahana Ahmed, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium studyJennifer A Doherty, Mary Anne Rossing, Kara L Cushing-Haugen, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Carcinogenesis|October 4, 2011
Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer StudyCatherine S Healey, Shahana Ahmed, , et al.
Human Molecular Genetics|August 1, 2013
A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer riskKaren A Pooley, Stig E Bojesen, Maren Weischer, et al.
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
Breast Cancer Research : BCR|October 8, 2016
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumTaru A Muranen, Carl Blomqvist, Thilo Dörk, et al.
Oncotarget|April 1, 2015
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patientsRainer Fagerholm, Marjanka K Schmidt, Sofia Khan, et al.
European Journal of Epidemiology|October 3, 2023
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancerKatharina Wichert, Reiner Hoppe, Katja Ickstadt, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Gynecologic Oncology|November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinomaNicola S Meagher, Phineas Hamilton, Katy Milne, et al.
Nature Genetics|April 19, 2011
Genome-wide association study identifies a common variant associated with risk of endometrial cancerAmanda B Spurdle, Deborah J Thompson, Shahana Ahmed, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium studyJennifer A Doherty, Mary Anne Rossing, Kara L Cushing-Haugen, et al.
Pageof 15